Showing 1 - 10 of 11,133
Persistent link: https://www.econbiz.de/10001568035
"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. This paper provides empirical evidence on how intellectual property (IP) on a given technology affects subsequent innovation. To shed...
Persistent link: https://www.econbiz.de/10003994910
Persistent link: https://www.econbiz.de/10003742537
Persistent link: https://www.econbiz.de/10009571566
Persistent link: https://www.econbiz.de/10011297589
Persistent link: https://www.econbiz.de/10011785403
Biologics accounted for roughly $145 billion in spending in 2018 (IQVIA, 2019). They are also the fastest growing segment of the pharmaceutical industry. The Biological Price Competition and Innovation Act (BPCIA) of 2010 created an abbreviated pathway for biosimilar products to promote price...
Persistent link: https://www.econbiz.de/10012496071
Persistent link: https://www.econbiz.de/10003262033
The advantages and disadvantages of genetic modification of organisms in agriculture are reviewed. These relate to the environment, human health, socio-economic effects, population growth, and differential consequences for developed and developing countries. An overall evaluation requires that...
Persistent link: https://www.econbiz.de/10011316889
In this paper, we analyze the extent to which market forces create an incentive for cloning human beings. We show that a market for cloning arises if a large enough fraction of the clone's income can be appropriated by its model. Only people with the highest ability are cloned, while people at...
Persistent link: https://www.econbiz.de/10001567024